029-83533393
   info@TaiBSbio.com
 
组织芯片,组织微阵列
 
UBD811膀胱癌及膀胱组织组合芯片,附TNM和临床分期,81例/81点
点 数81例 数81
行 数9列 数9
点直径(mm)1.5厚度(µm)5.0
组织阵列类型石蜡包埋种 属人类
QA/QCH&E and IHC confirmed
ApplicationsRoutine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better.

2.Bake the slides for 30 minutes at 60℃ before the experiment;

3.Please choose a gentle repair method to avoid tissue detachment.

产品名:UBD811
 
膀胱癌及膀胱组织组合微阵列芯片,包含63例尿路上皮癌,18例边缘或癌旁膀胱组织,一例一点
 
 
询价  Tel: 029-83533393
 
下载说明书
 
 
Legend:
Bla
-Bladder
 
AT (*)
 
Malignant (I)
 
Malignant (II)
 
Malignant (IIIA)
 
NAT (*)
TISSUE  ARRAYS UBD811
1
2
3
4
5
6
7
8
9
A
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
B
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
C
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
D
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
E
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
F
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
G
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
H
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
I
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
 
PosNoAgeSexOrgan_Anatomic_SitePathology_diagnosisGradeTNMStageTypeTumor SizeisBackUp
A1172MBladderLow-grade urothelial carcinoma*T3N0M0IIIAMalignant4*3*2N
A2251MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant6*4*2N
A3359FBladderLow-grade urothelial carcinoma*T1N0M0IMalignant4*3.5*3.5N
A4458MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant8*7*5N
A5579FBladderLow-grade urothelial carcinoma*T2N0M0IIMalignant10*5*1.5N
A6645FBladderLow-grade urothelial carcinoma*T1N0M0IMalignant3*2*1.5N
A7770MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant5*4*4N
A8856FBladderLow-grade urothelial carcinoma*T2N0M0IIMalignant6*5*0.5N
A9982FBladderLow-grade urothelial carcinoma*T1N0M0IMalignant3*3*2.5N
B11077MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant*N
B21172MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant5*5*2.5N
B31245MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant*N
B41342MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant4*3*3N
B51471MBladderLow-grade urothelial carcinoma*T2bN0M0IIMalignant4.5*3*2N
B61550MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant5*3*2N
B71670FBladderHigh grade urothelial carcinoma*T3aM0N0IIIAMalignant*N
B81765MBladderHigh grade urothelial carcinoma*T1N0M0IMalignant3*2*1N
B91878FBladderHigh grade urothelial carcinoma*T1N0M0IMalignant7*5*2N
C11950FBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*2N
C22038MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant10*8*3N
C32156MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*1N
C42248MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*2N
C52373FBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*2N
C62467MBladderHigh grade urothelial carcinoma*T3N0M0IIIAMalignant7*4*3N
C72571MBladderHigh grade urothelial carcinoma*T3bN0M0IIIAMalignant8*7N
C82645FBladderHigh grade urothelial carcinoma*T3N0M0IIIAMalignant10*7*7N
C92761MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant*N
D12882MBladderHigh grade urothelial carcinoma*T2bN0M0IIMalignant*N
D22970MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant5*2.5*2.5N
D33052MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant6*5*2N
D43169MBladderHigh grade urothelial carcinoma*T2aN0M0IIMalignant2.5*2.5*2.5N
D53267MBladderHigh grade urothelial carcinoma*T3N0M0IIIAMalignant*N
D63360FBladderHigh grade urothelial carcinoma*T3bN0M0IIIAMalignant3*2N
D73443FBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant*N
D83560MBladderHigh grade urothelial carcinoma*T3aM0N0IIIAMalignant3*2*2N
D93635MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant*N
E13742MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant*N
E23865MBladderHigh grade urothelial carcinoma*T1N0M0IMalignant3*3*1N
E33950MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*1N
E44065MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant2*2*1N
E54144MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant*N
E64270MBladderHigh grade urothelial carcinoma*T2bN0M0IIMalignant5*4*3N
E74342MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*1N
E84472MBladderHigh grade urothelial carcinoma*T1N0M0IMalignant*N
E94558MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant*N
F14679MBladderHigh grade urothelial carcinoma*T3N1M0IIIAMalignant4*3N
F24760FBladderHigh grade urothelial carcinoma*T3N0M0IIIAMalignant5.0N
F34853MBladderHigh grade urothelial carcinoma*T3N1M0IIIAMalignant*N
F44956MBladderHigh grade urothelial carcinoma*T3N0M0IIIAMalignant*N
F55053MBladderHigh grade urothelial carcinoma*T3bN0M0IIIAMalignant5*4*2N
F65133MBladderHigh grade urothelial carcinoma*T3N1M0IIIAMalignant*N
F75265FBladderHigh grade urothelial carcinoma*T3aM0N0IIIAMalignant4*3*2N
F85368MBladderHigh grade urothelial carcinoma*T3N0M0IIIAMalignant*N
F95474MBladderHigh grade urothelial carcinoma*T3N0M0IIIAMalignant*N
G15577FBladderHigh grade urothelial carcinoma*T1N0M0IMalignant2*1.5*1N
G25666MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*3*2N
G35737FBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant*N
G45845FBladderHigh grade urothelial carcinoma*T1N0M0IMalignant*N
G55955MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*1.5N
G66025FBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant13*10*8N
G76170FBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*2N
G86266MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant*N
G96359MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant*N
H16454MBladderCancer adjacent bladder tissue***AT*N
H26540FBladderCancer adjacent bladder tissue***AT*N
H36655MBladderAdjacent normal bladder tissue***NAT*N
H46775MBladderCancer adjacent bladder tissue***AT*N
H56845MBladderAdjacent normal bladder tissue***NAT*N
H66973MBladderCancer adjacent bladder tissue***AT*N
H77072MBladderCancer adjacent bladder tissue***AT*N
H87163MBladderAdjacent normal bladder tissue***NAT*N
H97258MBladderCancer adjacent bladder tissue***AT*N
I17368MBladderCancer adjacent bladder tissue***AT*N
I27460MBladderCancer adjacent bladder tissue***AT*N
I37550FBladderCancer adjacent bladder tissue (high grade urothelial carcinoma)***AT*N
I47652MBladderCancer adjacent bladder tissue***AT*N
I57751MBladderAdjacent normal bladder tissue***NAT*N
I67854FBladderCancer adjacent bladder tissue***AT*N
I77978FBladderCancer adjacent bladder tissue***AT*N
I88037FBladderAdjacent normal bladder tissue***NAT*N
I98151MBladderAdjacent normal bladder tissue***NAT*N
Tissue Marker
 
 
西安泰博斯生物科技有限公司

 
联系我们
地址:陕西西安市灞桥区长乐东路2999号
电话:029-83533393, 17792711553,
电子邮箱:taibsbio@163.com
QQ:3144647811
微信号:13002913390
邮政编码:710075
关于我们
西安泰博斯生物科技有限公司主要经营组织芯片的研发、销售,加工定制和与组织芯片有关的生物技术服务项目。公司目前拥有专业的病理医生和技术研发团队,并且具有庞大的组织标本库。样本库中组织微阵列种类多,病理类型齐全,同时根据客户需求情况进行制作加工新的组织微阵列,尽量满足每一个客户的需求。公司一直秉承着“认真、严谨、负责”的工作态度,致力于为广大客户提供质量好的产品和优质的服务。

更多详情